World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Keywords:
Tags:
Abbott's decision to raise the price of AIDS drug Norvir 5 fold in 2003, and how it undercut Glaxo's drug Lexiva which is used in combination with Norvir. Abbott included Norvir ingredients in a new drug Kaletra and this was priced cheaper than other AIDS drugs when it increased the price of Norvir. Glaxio is now suing Abbott for this pricing practice.
Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.
06/09/2007
Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
New York Times 12/21/2013
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Settlement May Cut Drug Prices
Wall Street Journal 06/09/2007
Abbott Laboratories.
06/18/2007
Grouped Articles
Abbott Breaks With Industry, Sues AIDS Group
Wall Street Journal 06/18/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Abbott to Pay $184 Million In Tricor Suits
Wall Street Journal 11/21/2008
The Unmasking Of Company X Abbott Labs Approached
Wall Street Journal 03/31/2009
Abbott Joins Bidding for Solvay Drug Unit
Wall Street Journal 09/25/2009
Abbott in $6.6 Billion Deal for Drug Unit
New York Times 09/28/2009
Glaxo's settlement for aggressive marketing and its overhaul of its marketing effort.
04/10/2007
A $400 million settlement for off-label promotion of Paxil and Wellbutrin antidepressant drugs.
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Glaxo Braces for Probes, Hires FDA Ex-Litigator
Wall Street Journal 07/23/2008
Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force
Wall Street Journal 11/06/2008
Pharmaceutical company pricing in the U.S. and Europe
11/09/2007
The pricing of pharmaceutical products and healthcare services in the U.S. and Europe.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08/07/2009
Economist 08/27/2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01/11/2010
Large legal settlements in the pharmaceutical industry.
10/25/2006
The settlements also involve drug pricing and marketing.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
In Guilty Plea, OxyContin Maker to Pay $600 Million
New York Times 05/10/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Approval Is Not a Shield From Lawsuits, Justices Rule
New York Times 03/05/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us